Introduction
Alpha-Lipoic Acid (ALA) is one of the most relevant ingredients in modern nutraceutical formulations, thanks to its central role in cellular energy metabolism and its broad-spectrum antioxidant activity. Its use is well established in metabolic and neurological support, as well as in healthy aging strategies.
However, the practical effectiveness of ALA is often limited by formulation challenges that affect absorption, tolerability, and compliance. In this context, MATRIS® technology, developed by IPS, offers an advanced microencapsulation approach designed to control release and improve bioaccessibility.
Properties and application fields of Alpha-Lipoic Acid
ALA is an essential cofactor of mitochondrial enzyme complexes and exerts key functions across several physiological areas:
- Metabolic support
Widely used in nutritional strategies aimed at glucose metabolism and insulin sensitivity. - Systemic antioxidant activity
Active in both hydrophilic and lipophilic environments, contributing to free radical neutralization and regeneration of endogenous antioxidants. - Neurological and neuro-metabolic support
Applied in conditions associated with neuronal oxidative stress and altered energy metabolism. - Healthy aging and sport nutrition
Supporting mitochondrial function and energy recovery in active and adult populations.
Formulation challenges of ALA
Despite its strong scientific rationale, ALA presents intrinsic limitations:
- instability and gastricdegradation
- rapid and uncontrolled release
- unpredictableintestinalabsorption
- gastric sensitivity and reflux
- strong taste and odor affecting compliance
These factors highlight the need for a functional technological approach rather than simple ingredient inclusion.
IPS innovation: ALA MATRIS® FAST and ALA MATRIS® RETARD
IPS has developed two Alpha-Lipoic Acid references functionalized through MATRIS® technology, a direct microencapsulation of the active (not supported on inert cores), designed to modulate its interaction with the gastrointestinal tract.
- Immediate release in the digestive tract
- Effective taste masking
- Improved tolerability compared to raw ALA
- Suitable for fast-action formulations
- Controlled and prolonged release
- Improvedintestinalbioaccessibility
- Reducedconcentrationpeaks
- Lower gastric sensitivity
- Suitable for long-term and structured metabolic protocols
In both versions, the coating system is designed to modulate release without altering the nature of the active ingredient.
Scientific evidence
For Alpha-Lipoic Acid MATRIS®, IPS has generated direct preclinical evidence.
Advanced in vitro studies, conducted on human 3D models and intestinal, gastric, and neuronal organoids, compared raw ALA with MATRIS®-formulated ALA.
The resultsdemonstrated:
- more gradual and modulated release of ALA MATRIS®
- improved interaction with the intestinal epithelium
- reduced impact on gastric and intestinal membranes
- improvedsafety and tolerabilityprofile
- greater effectiveness on the peripheral nervous system
These findings confirm that the observed benefits are directly attributable to MATRIS® technology, validating microencapsulation as a functional tool rather than a purely technological solution.
Formulations and applications
ALA MATRIS® FAST and ALA MATRIS® RETARD are compatible with the main nutraceutical dosage forms:
- capsules
- tablets
- sachets / stick packs
- single-dose vials with dosing caps
- SmarTTabs®, IPS technological innovation, for direct compression while preserving the release profile
This versatility allows formulators to select the most appropriate technological profile for their nutritional objectives.
Conclusion
Alpha-Lipoic Acid is a high-value nutraceutical active, but only an advanced formulation approach enables its full potential.
With ALA MATRIS® FAST and ALA MATRIS® RETARD, IPS demonstrates how MATRIS® technology can transform a critical raw material into a scientifically validated, functionally optimized ingredient.
SURACTIVES® is confirmed as a technology provider, applying proprietary solutions to enhance the real effectiveness of nutraceutical ingredients.
Note: This article is provided for informational purposes only and does not substitute professional medical advice.
